PROCEPT BioRobotics (PRCT) Net Margin (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Net Margin data on file, last reported at 38.06% in Q1 2026.

• On a quarterly basis, Net Margin fell 229.0% year-over-year to 38.06% in Q1 2026; TTM through Mar 2026 was 57.71%, a 1272.0% decrease from a year earlier, with the FY2025 full-year figure at 31.02%, up 969.0% from the prior year.
• Net Margin for Q1 2026 stood at 38.06%, up from 42.74% in the prior quarter.
• Over the last five years, Net Margin for PRCT reached as high as 30.29% in Q4 2024 and fell as low as 319.44% in Q1 2023.
• Historically, Net Margin has averaged 98.05% across 5 years, with a median of 76.81% in 2025.
• Across the five-year window, Net Margin tumbled 18111 bps in 2023 and soared 22617 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 100.82% in 2022, then surged by 30 bps to 70.4% in 2023, then soared by 57 bps to 30.29% in 2024, then plunged by 41 bps to 42.74% in 2025, then gained by 11 bps to 38.06% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 38.06% in Q1 2026, 42.74% in Q4 2025, and 72.9% in Q3 2025.